Skip to content

Trauma Induced Coagulopathy and Inflammation

Trauma Induced Coagulopathy and Inflammation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03128658
Acronym
TrICI
Enrollment
300
Registered
2017-04-25
Start date
2017-02-27
Completion date
2020-12-31
Last updated
2021-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma Injury, Trauma, Coagulopathy

Keywords

Trauma induced coagulopathy

Brief summary

While a number of factors are known to be associated with the development of trauma induced coagulopathy (TIC), inflammation, and multi-organ failure, we currently cannot predict which patients are at risk for developing these life threatening conditions with any certainty. In this prospective observational study, we will investigate the many factors that contribute to the development of trauma induced coagulopathy, post injury inflammation and the development of organ dysfunction in order to develop a multi scale computational algorithm of clinical prediction. Using a convenience sample technique, demographic data, physiologic data, blood samples and clinical variables will be collected over 5 days following traumatic injury. A computational model will be used to predict the development of TIC and multi-organ failure.

Detailed description

A prospective, observational, convenience sample of trauma patients 18 years old or older who present to the trauma bay as a trauma alert will be included after evaluation by the on-call trauma surgeon and research assistant. Minimally injured patients will be compared to those with a systolic blood pressure of 90 mmHg or less, the need for blood product transfusion within 1 hour of admission, and/or an ISS (injury severity score) of greater than or equal to 15. Demographic data including past medical/medication history as well as clinical data including continuous vital signs will be recorded. If eligibility criteria are met, the research blood samples will be drawn at the same time as routine clinical samples. Blood samples (approximately 15 ml) will be taken on admission, 3hr, 6hrs, 12hrs, 24 hrs, 48 hrs, and 5 days post admission. Vital signs, number of blood transfusions, volume of crystalloid, administration of medications, and the values of routine laboratories will be monitored continuously for 24 hours, and then cumulatively for up to 5 days. After the last blood draw, we will be following the patient's outcome for up to 30 days. If patients are discharged or die prior to completing the 5 days of blood samples, additional samples and/or clinic appointments for the purpose of research will not be obtained. A computational algorithm will be used to predict the development of trauma induced coagulopathy, inflammation and multi-organ failure.

Interventions

DIAGNOSTIC_TESTThromboelastography

Thromboelastography (TEG) tests for parameters related to efficiency of blood coagulation. The parameters are: reaction time (R value), the K value, the angle and the maximum amplitude (MA)

DIAGNOSTIC_TESTComputational model

The computational whole-patient systems model is a multiscale, multi-compartment model whose state-space is defined by a very large and heterogeneous set of variables as well as a large number of input parameters. The model will be integrated in time for various initial trauma conditions in an attempt to determine whether the model can be predictive, and help us discover new variables that are more predictive of clinical outcomes than those employed in current clinical protocols.

Sponsors

Princeton University
CollaboratorOTHER
University of Pennsylvania
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Injured patients presenting to the trauma bay with a trauma alert activation (highest level of activation) * Age 18 years old or more

Exclusion criteria

* Transfer duration to trauma service exceeding 6 hours. * Known pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Change in Thromboelastography parameters T0 -T3Between time of admission (T0) and 3 hours (T3)Variables: Reaction time (R value), the K value, the angle and the maximum amplitude (MA)
Change in Thromboelastography parameters T3 -T6Between 3 hours (T3) and 6 hours (T6)Variables: Reaction time (R value), the K value, the angle and the maximum amplitude (MA)
Change in Thromboelastography parameters T6 -T12Between 6 hours (T6) and 12 hours (T12)Variables: Reaction time (R value), the K value, the angle and the maximum amplitude (MA)
Change in Thromboelastography parameters T12 - T24Between 12 hours (T12) and 24 hours (T24)Variables: Reaction time (R value), the K value, the angle and the maximum amplitude (MA)
Change in Thromboelastography parameters T24 - T48Between 24 hours (T24) and 48 hours (T48)Variables: Reaction time (R value), the K value, the angle and the maximum amplitude (MA)
Change in Thromboelastography parameters T48 - T120Between 48 hours (T48) and 120 hours (T120)Variables: Reaction time (R value), the K value, the angle and the maximum amplitude (MA)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026